SCHEMBL351125

SCHEMBL351125

Nc1ccc(Nc2ccc(-c3ccc(Nc4ccc(N)cc4)cc3)cc2)cc1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 8/20 0.67
ALDH1A1 P00352 5/20 0.67
CYP3A4 P08684 3/20 0.67
L3MBTL1 Q9Y468 3/20 0.67
ALOX12 P18054 2/20 0.67
CYP1A2 P05177 1/20 0.67
CYP2C9 P11712 1/20 0.67
CYP2C19 P33261 1/20 0.67
HTT P42858 1/20 0.67
TDP1 Q9NUW8 4/20 0.65
TP53 P04637 3/20 0.65
RAD52 P43351 1/20 0.61
NR4A1 P22736 1/20 0.56
HSD17B10 Q99714 4/20 0.52
TAAR1 Q96RJ0 1/20 0.52
KDM4E B2RXH2 3/20 0.50
ALOX15 P16050 2/20 0.50
HPGD P15428 2/20 0.50
SMN1; SMN2 Q16637 2/20 0.50
APP P05067 2/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6301188 1.00 MAPT (0.67) MAPTALDH1A1CYP3A4L3MBTL1ALOX12
SCHEMBL9518383 1.00 MAPT (0.67) MAPTALDH1A1CYP3A4L3MBTL1ALOX12
SCHEMBL5428343 0.91 MAPT (0.78) MAPTALDH1A1CYP3A4L3MBTL1ALOX12
SCHEMBL5438258 0.91 MAPT (0.78) MAPTALDH1A1CYP3A4L3MBTL1ALOX12
SCHEMBL12747008 0.91 MAPT (0.78) MAPTALDH1A1CYP3A4L3MBTL1ALOX12
SCHEMBL18289620 0.91 MAPT (0.78) MAPTALDH1A1CYP3A4L3MBTL1ALOX12
SCHEMBL33864 0.91 MAPT (0.78) MAPTALDH1A1CYP3A4L3MBTL1ALOX12
SCHEMBL2478605 0.90 MAPT (0.86) MAPTALDH1A1CYP3A4L3MBTL1ALOX12
SCHEMBL7007688 0.90 MAPT (0.86) MAPTALDH1A1CYP3A4L3MBTL1ALOX12
SCHEMBL5803919 0.90 MAPT (0.77) MAPTALDH1A1CYP3A4L3MBTL1ALOX12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 178 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180066110-A1 NOVEL POLYAMIDEIMIDE HAVING LOW THERMAL EXPANSION COEFFICIENT KOREA ADVANCED INST SCI & TECH (KR) 2018-03-08 US claimed
US-20160194449-A1 NOVEL POLYAMIDEIMIDE HAVING LOW THERMAL EXPANSION COEFFICIENT KOREA ADVANCED INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2016-07-07 US claimed
EP-2940015-A1 NOVEL POLYAMIDEIMIDE HAVING LOW THERMAL EXPANSION COEFFICIENT Korea Advanced Institute of Science and Technology (KR) 2015-11-04 EP claimed
CN-122037960-A Liquid crystal aligning agent, liquid crystal alignment film, method for producing liquid crystal alignment film, liquid crystal element, and method for producing liquid crystal element JSR株式会社 2026-05-15 CN disclosed
US-20250257265-A1 LIQUID CRYSTAL ALIGNING AGENT, LIQUID CRYSTAL ALIGNMENT FILM AND LIQUID CRYSTAL DISPLAY ELEMENT NISSAN CHEMICAL CORPORATION (JP) 2025-08-14 US disclosed
WO-2025127092-A1 LIQUID CRYSTAL ALIGNMENT AGENT, LIQUID CRYSTAL ALIGNMENT FILM, AND LIQUID CRYSTAL DISPLAY ELEMENT 日産化学株式会社 2025-06-19 WO disclosed
WO-2025121189-A1 LIQUID CRYSTAL ALIGNMENT AGENT, LIQUID CRYSTAL ALIGNMENT FILM, AND LIQUID CRYSTAL DISPLAY ELEMENT 日産化学株式会社 2025-06-12 WO disclosed
WO-2025121249-A1 LIQUID CRYSTAL ALIGNING AGENT, LIQUID CRYSTAL ALIGNMENT FILM AND LIQUID CRYSTAL DISPLAY ELEMENT 日産化学株式会社 2025-06-12 WO disclosed
CN-120059762-A Liquid crystal aligning agent for forming weak anchor film, method for producing liquid crystal aligning film, and method for producing liquid crystal element JSR株式会社 2025-05-30 CN disclosed
WO-2025105278-A1 LIQUID CRYSTAL ALIGNMENT AGENT, LIQUID CRYSTAL ALIGNMENT FILM, AND LIQUID CRYSTAL DISPLAY ELEMENT 日産化学株式会社 2025-05-22 WO disclosed
WO-2025105279-A1 LIQUID CRYSTAL ALIGNMENT AGENT, LIQUID CRYSTAL ALIGNMENT FILM, AND LIQUID CRYSTAL DISPLAY ELEMENT 日産化学株式会社 2025-05-22 WO disclosed
US-8496849-B2 Liquid crystal aligning agent, liquid crystal alignment film and liquid crystal display device JSR CORPORATION (JP) 2013-07-30 US disclosed
EP-2256541-B1 A LIQUID CRYSTAL ORIENTATING AGENT, A LIQUID CRYSTAL ORIENTATING FILM AND A LIQUID CRYSTAL DISPLAY ELEMENT JSR CORP (JP) 2012-12-05 EP disclosed
US-20120013837-A1 COMPOSITION FOR FORMING LIQUID CRYSTAL ALIGNMENT FILM AND LIQUID CRYSTAL DISPLAY DEVICE SHARP KABUSHIKI KAISHA (JP) 2012-01-19 US disclosed
US-8057868-B2 Composition for forming a liquid crystal alignment film, and liquid crystal display device SHARP KABUSHIKI KAISHA (JP) 2011-11-15 US disclosed
EP-2375278-A1 COMPOSITION FOR FORMING LIQUID CRYSTAL ALIGNMENT FILM AND LIQUID CRYSTAL DISPLAY DEVICE Sharp Kabushiki Kaisha (JP) 2011-10-12 EP disclosed
US-20110043739-A1 LIQUID CRYSTAL ALIGNING AGENT, LIQUID CRYSTAL ALIGNMENT FILM AND LIQUID CRYSTAL DISPLAY DEVICE JSR CORPORATION (JP) 2011-02-24 US disclosed
US-20110007254-A1 COMPOSITION FOR FORMING A LIQUID CRYSTAL ALIGNMENT FILM, AND LIQUID CRYSTAL DISPLAY DEVICE SHARP KABUSHIKI KAISHA (JP) 2011-01-13 US disclosed
EP-2259133-A1 COMPOSITION FOR FORMING LIQUID CRYSTAL ALIGNMENT FILM AND LIQUID CRYSTAL DISPLAY DEVICE Sharp Kabushiki Kaisha (JP) 2010-12-08 EP disclosed
EP-2256541-A1 A LIQUID CRYSTAL ORIENTATING AGENT, A LIQUID CRYSTAL ORIENTATING FILM AND A LIQUID CRYSTAL DISPLAY ELEMENT JSR Corporation (JP) 2010-12-01 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180066110-A1 NOVEL POLYAMIDEIMIDE HAVING LOW THERMAL EXPANSION COEFFICIENT RICTOR, SGTA, SLC43A1 MAPT 524/4885ALDH1A1 1659/4885CYP3A4 4322/4885
US-20160194449-A1 NOVEL POLYAMIDEIMIDE HAVING LOW THERMAL EXPANSION COEFFICIENT SGTA, RICTOR, SLC43A1 MAPT 394/4885ALDH1A1 1627/4885CYP3A4 4328/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.